LYNCBIO Trademark

Trademark Overview


On Tuesday, January 21, 2025, a trademark application was filed for LYNCBIO with the United States Patent and Trademark Office. The USPTO has given the LYNCBIO trademark a serial number of 79419542. The federal status of this trademark filing is PUBLICATION/ISSUE REVIEW COMPLETE as of Monday, September 22, 2025. This trademark is owned by LYNCBIO THERAPEUTICS CO., LTD.. The LYNCBIO trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Technological research in the field of pharmaceuticals; research and development of new products for others; analysis of the mode of action of chemical combinations on animals; product quality testing; biochemical research and analysis; medical and scientific research, namely, conducting clinical trials for others; development of pharmaceutical preparations and medicines; pharmaceutical research and development; scientific research for medical purposes in the area of cancerous diseases; biomedical research services; conducting early evaluations in the field of new pharmaceuticals; testing of pharmaceuticals
lyncbio

General Information


Serial Number79419542
Word MarkLYNCBIO
Filing DateTuesday, January 21, 2025
Status681 - PUBLICATION/ISSUE REVIEW COMPLETE
Status DateMonday, September 22, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 14, 2025

Trademark Statements


Goods and ServicesTechnological research in the field of pharmaceuticals; research and development of new products for others; analysis of the mode of action of chemical combinations on animals; product quality testing; biochemical research and analysis; medical and scientific research, namely, conducting clinical trials for others; development of pharmaceutical preparations and medicines; pharmaceutical research and development; scientific research for medical purposes in the area of cancerous diseases; biomedical research services; conducting early evaluations in the field of new pharmaceuticals; testing of pharmaceuticals

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, March 20, 2025
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameLYNCBIO THERAPEUTICS CO., LTD.
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressCN

Trademark Events


Event DateEvent Description
Thursday, March 20, 2025SN ASSIGNED FOR SECT 66A APPL FROM IB
Friday, March 21, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, March 21, 2025APPLICATION FILING RECEIPT MAILED
Monday, June 30, 2025ASSIGNED TO EXAMINER
Tuesday, July 1, 2025NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Wednesday, August 13, 2025REFUSAL PROCESSED BY MPU
Friday, August 29, 2025REFUSAL PROCESSED BY IB
Wednesday, September 10, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, September 10, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, September 10, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, September 12, 2025APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, August 13, 2025NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Monday, June 30, 2025NON-FINAL ACTION WRITTEN